Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
First Affiliated Hospital, Sun Yat-Sen University
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Ohio State University
Aarhus University Hospital
Mayo Clinic
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
National Institutes of Health Clinical Center (CC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Oslo University Hospital
Qilu Hospital of Shandong University
Johns Hopkins University
Zhejiang University
National Institutes of Health Clinical Center (CC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tata Memorial Centre
Mayo Clinic
MarÃa Teresa Moreno Asencio
Shanghai Zhongshan Hospital